ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646161; 2) Community: the network communities that were significantly associated with the response to NSC 646161; 3) Molecule: the relationships between components within communities and NSC 646161; 4) MDR: the compounds that were significantly associated with the NSC 646161.

NSC Compound Enrichment Correlation
NSC 761814 3-(4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole 0.0404100698195781 0.35150598
NSC 83459 Indole-2,3-dione, 3-(4,4-dimethyl-3-thiosemicarbazone) 0.0404100698195781 0.4634842
NSC 116878 Cardiac glycoside 0.0421163101172308 0.10814975
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 0.0421163101172308 0.52174215
NSC 13317 Null 0.0421163101172308 0.18878286
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0421163101172308 0.43812627
NSC 281383 Null 0.0421163101172308 0.45620013
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.0421163101172308 0.16069731
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0421163101172308 0.51539426
NSC 46213 Null 0.0421163101172308 -0.40121522
Total:100  Current:90    [First] [Prev] [Next] [Last]